Jarosław Markowski

Prof. Dr. Jarosław Markowski

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 December 2020 in Biomolecules
Verified
Journal Article
Open access
PDF file
Parvaneh MehrbodParvaneh Mehrbod
Parvaneh Mehrbod
DHDorota Hudy
Dorota Hudy
DSDivine Yufetar Shyntum
Divine Yufetar Shyntum
JMJarosław Markowski
Jarosław Markowski
Marek J. ŁosMarek J. Łos
Marek J. Łos
Saeid GhavamiSaeid Ghavami
Saeid Ghavami
The medical burden caused by respiratory manifestations of influenza virus (IV) outbreak as an infectious respiratory disease is so great that governments in both developed and developing countries have allocated significant national budget toward the development of strategies for prevention, control, and treatment of this infection, which is seemingly common and treatable, but can be deadly. Frequent mutations in its genome structure often result in resistance to standard medications. Thus, new generations of treatments are critical to combat this ever-evolving infection. Plant materials and active compounds have been tested for many years, including, more recently, active compounds like flavonoids. Quercetin is a compound belonging to the flavonols class and has shown therapeutic effects against influenza virus. The focus of this review includes viral pathogenesis as well as the application of quercetin and its derivatives as a complementary therapy in controlling influenza and its related symptoms based on the targets. We also touch on the potential of this class of compounds for treatment of SARS-COV-2, the cause of new pandemic.

4 February 2014 in The Scientific World Journal
Verified
Journal Article
Open access
PDF file
WLWirginia Likus
Wirginia Likus
GBGrzegorz Bajor
Grzegorz Bajor
KGKatrzyna Gruszczyńska
Katrzyna Gruszczyńska
JBJan Baron
Jan Baron
JMJarosław Markowski
Jarosław Markowski
TLTomasz Lepich
Tomasz Lepich
Cephalic index is a highly useful method for planning surgical procedures, as well as assessing their effectiveness in correcting cranial deformations in children. There are relatively very few studies measuring cephalic index in healthy Caucasian young children. The aim of our study was to develop a classification of current cephalic index for healthy Caucasian children up to 3 years of age with normal brain development, using axial slice computer tomography performed with very thin slices (0.5 mm) resulting in more accurate measurements. 180 healthy infants (83 females and 97 males) were divided into 5 age categories: 0–3, 4–6, 7–12, 13–24, and 25–36 months. The average value of cephalic index in children up to 3 years of age amounted to 81.45 ± 7.06. The index value in case of children under 3 months was 80.19, 4 to 6 months was 81.45, 7 to 12 months was 83.15, in children under 2 years was 81.05, and in children under 3 years was 79.76. Mesocephaly is the dominating skull shape in children. In this study, we formulated a classification of current cephalic indices of children with normal brain development. Our date appears to be of utmost importance in anthropology, anatomy forensic medicine, and genetics.

23 October 2014 in Molecular Pharmaceutics
Verified
Journal Article
Closed access
Justyna Knapik-KowalczukJustyna Knapik-Kowalczuk
Justyna Knapik-Kowalczuk
ZWZ. Wojnarowska
Z. Wojnarowska
KGKatarzyna Anna Grzybowska
Katarzyna Anna Grzybowska
Łukasz HawełekŁukasz Hawełek
Łukasz Hawełek
WSW. Sawicki
W. Sawicki
MPM. Paluch
M. Paluch

26 September 2013 in Molecular Pharmaceutics
Verified
Journal Article
Closed access
ZWZaneta Wojnarowska
Zaneta Wojnarowska
KGKatarzyna Anna Grzybowska
Katarzyna Anna Grzybowska
Łukasz HawełekŁukasz Hawełek
Łukasz Hawełek
Mateusz DulskiMateusz Dulski
Mateusz Dulski
RWR. Wrzalik
R. Wrzalik
JMJarosław Markowski
Jarosław Markowski

26 March 2012 in Molecular Pharmaceutics
Verified
Journal Article
Closed access
ZWZaneta Wojnarowska
Zaneta Wojnarowska
KGKatarzyna Anna Grzybowska
Katarzyna Anna Grzybowska
Łukasz HawełekŁukasz Hawełek
Łukasz Hawełek
ASA. Swiety-Pospiech
A. Swiety-Pospiech
EMElżbieta Masiewicz
Elżbieta Masiewicz
JMJarosław Markowski
Jarosław Markowski

1 January 2017 in Journal of Nanomaterials
Verified
Journal Article
Open access
PDF file
AMAnna Magiera
Anna Magiera
JMJarosław Markowski
Jarosław Markowski
EMElzbieta Menaszek
Elzbieta Menaszek
JPJan Pilch
Jan Pilch
SBStanislaw Blazewicz
Stanislaw Blazewicz
The aim of the study was to manufacture poly(lactic acid)- (PLA-) based nanofibrous nonwovens that were modified using two types of modifiers, namely, gelatin- (GEL-) based nanofibres and carbon nanotubes (CNT). Hybrid nonwovens consisting of PLA and GEL nanofibres (PLA/GEL), as well as CNT-modified PLA nanofibres with GEL nanofibres (PLA + CNT/GEL), in the form of mats, were manufactured using concurrent-electrospinning technique (co-ES). The ability of such hybrid structures as potential scaffolds for tissue engineering was studied. Both types of hybrid samples and one-component PLA and CNTs-modified PLA mats were investigated using scanning electron microscopy (SEM), water contact angle measurements, and biological and mechanical tests. The morphology, microstructure, and selected properties of the materials were analyzed. Biocompatibility and bioactivity in contact with normal human osteoblasts (NHOst) were studied. The coelectrospun PLA and GEL nanofibres retained their structures in hybrid samples. Both types of hybrid nonwovens were not cytotoxic and showed better osteoinductivity in comparison to scaffolds made from pure PLA. These samples also showed significantly reduced hydrophobicity compared to one-component PLA nonwovens. The CNT-contained PLA nanofibres improved mechanical properties of hybrid samples and such a 3D system appears to be interesting for potential application as a tissue engineering scaffold.